Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).
Rehberg S, Frank S, Černý V, Cihlář R, Borgstedt R, Biancofiore G, Guarracino F, Schober A, Trimmel H, Pernerstorfer T, Siebers C, Dostál P, Morelli A, Joannidis M, Pretsch I, Fuchs C, Rahmel T, Podbregar M, Duliczki É, Tamme K, Unger M, Sus J, Klade C, Krejcy K, Kirchbaumer-Baroian N, Krumpl G, Duška F; LANDI-SEP Study Group.
Rehberg S, et al. Among authors: joannidis m.
Intensive Care Med. 2024 Oct;50(10):1622-1634. doi: 10.1007/s00134-024-07587-1. Epub 2024 Sep 19.
Intensive Care Med. 2024.
PMID: 39297945
Free PMC article.
Clinical Trial.